Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Antiviral Res. 2020 Mar 23;177:104777. doi: 10.1016/j.antiviral.2020.104777

Table 3.

Aniline derivatives

HBV replication inhibition HBV RNaseH inhibiton
Entry Compound number NR1R1 EC50 (μM) CC50 (μM) SI IC50 (μM)
1 389 graphic file with name nihms-1581389-t0032.jpg 0.43 ± 0.23 21.2 ± 9.5 49.3 200 ± 190
2 711 graphic file with name nihms-1581389-t0033.jpg 0.75 ± 0.35 4.6 ± 0.8 6.1 NA
3 836 graphic file with name nihms-1581389-t0034.jpg 3.32 ± 0.67 5.4 ± 3.5 1.7 78.9 ± 49
4 799 graphic file with name nihms-1581389-t0035.jpg 3.25 ± 0.78 5.3 ± 3.1 1.6 78.5 ± 60
5 798 graphic file with name nihms-1581389-t0036.jpg 3.47 ± 0.49 3.3 ± 1.8 0.9 58.3 ± 49
6 835 graphic file with name nihms-1581389-t0037.jpg 5.07 ± 2.45 10.3 ± 5.2 2 86.0 ± 42
7 834 graphic file with name nihms-1581389-t0038.jpg 5.30 ± 0.10 16.4 ± 11.2 3.1 83.5 ± 69
8 837 graphic file with name nihms-1581389-t0039.jpg 6.0 ± 1.98 8.7 ± 3.4 1.5 119 ± 89